Clinical Trial: A Single-Center, Single-Arm Exploratory Study on the Efficacy of Crisugabalin Combined with Flupentixol and Melitracen Tablets in the Treatment of Headache Patients with Anxiety and Depression (China)

China, Oct. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Single-Center, Single-Arm Exploratory Study on the Efficacy of Crisugabalin Combined with Flupentixol and Melitracen Tablets in the Treatment of Headache Patients with Anxiety and Depression'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600135375

Registration Time: 2026/10/29

Type: Interventional study

Primary Sponsor: Tongji Hospital, Tongji Medical College ,Huazhong University of Science and Technology

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=304193

Published by HT Digital Content Services with permission from Health Daily Digest....